Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

PHILADELPHIA, January 22 /PRNewswire/ --

ExploTrack, Inc. is pleased to announce that the Saudi Chemical Company has taken an investment position in its company, which provides breakthrough technical solutions that detect, track, monitor, and identify explosives in real-time and enable unprecedented supply-chain security. In doing so, the Saudi Chemical Company is demonstrating leadership as a Middle Eastern entity committed to the goal of global explosives security.

NOVATO, California., and LONDON, January 22 /PRNewswire/ --

BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced today that it has appointed Mr. Steve Glass as Vice President and General Manager of European Operations. BioMarin Europe Ltd., headquartered in London, is responsible for the sales and distribution of Naglazyme(R) for MPS VI (mucopolysaccharidosis VI) in Europe. Mr. Glass is the former General Manager for Altana/Nycomed, France. He has replaced former Vice President and General Manager, William Aliski who played an instrumental role in the successful launch of Naglazyme in Europe and the establishment of BioMarin's first international commercial operation.

RAMAT GAN, Israel, January 22 /PRNewswire/ --

- Simple, Accurate and Flexible Comparison, Synchronization and Replication Across any Database

DBBalance the leading provider of database data and structure comparison, synchronization and migration solutions has released version 6.0 of the Cross Database suite of products. Serving hundreds of customers, DBBalance is committed to providing state of the art solutions for developers, DBAs and IT managers. The new version includes significant improvements in performance, ease of use and enhanced security. Version 6.0 includes the following improvements:

- Enhanced performance

- Build in award winning set of ODBC drivers

- Multi-transaction mode

- Database structure Filters

LOS ANGELES, January 22 /PRNewswire/ --

- Mike Franzino to Take on Global Role

MOSCOW, January 22 /PRNewswire/ --

Mechel OAO (NYSE: MTL), one of the leading Russian mining and metals companies, announces the appointment of Stanislav Ploschenko as its Chief Financial Officer effective immediately.

Previously, Mr. Ploschenko (31) was Mechel OAO's Acting Chief Financial Officer. As Chief Financial Officer, he will continue to be responsible for strategic development of Mechel's Finance Division, financial policies and planning, US GAAP reporting, implementation of internal controls, integration and unification of Mechel subsidiaries' operations, and operational management of the financial units.

ST. DAVID'S, Bermuda, January 22 /PRNewswire/ --

Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will issue its 2008 Financial Guidance prior to the market open on Monday, January 28, 2008. In addition to issuing a press release, Paul Herendeen, Executive Vice President and Chief Financial Officer will host a conference call and audio webcast to discuss the 2008 Financial Guidance for all interested parties at 8:30 a.m. EST on Monday, January 28, 2008.